Stephanie Viennot - Publications

Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study.

Journal: Journal of Crohn's & colitis

Published: August 25, 2025

Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort.

Journal: Journal of Crohn's & colitis

Published: November 02, 2024

Gastrointestinal bleeding of undetermined origin: What diagnostic strategy to propose?

Journal: Journal of visceral surgery

Published: June 21, 2023

Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.

Journal: Journal of Crohn's & colitis

Published: March 29, 2023

Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 26, 2023

Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.

Journal: BMC gastroenterology

Published: February 02, 2023

How to manage lower gastrointestinal bleeding in 2022?

Journal: Journal of visceral surgery

Published: November 15, 2022

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.

Journal: Infection prevention in practice

Published: October 10, 2022

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.

Journal: The lancet. Gastroenterology & hepatology

Published: July 15, 2022

Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.

Journal: Scandinavian journal of gastroenterology

Published: July 12, 2022

Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.

Journal: BMC gastroenterology

Published: June 05, 2022

Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 13, 2022